These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17855631)

  • 1. Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.
    Boffa MB; Maret D; Hamill JD; Bastajian N; Crainich P; Jenny NS; Tang Z; Macy EM; Tracy RP; Franco RF; Nesheim ME; Koschinsky ML
    Blood; 2008 Jan; 111(1):183-9. PubMed ID: 17855631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
    Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
    Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3'-untranslated region.
    Novakovic D; Kuo AC; Lin JH; Koschinsky ML; Boffa MB
    J Thromb Haemost; 2012 May; 10(5):887-94. PubMed ID: 22452791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability.
    Masuda Y; Saotome D; Takada K; Sugimoto K; Sasaki T; Ishii H
    Thromb Haemost; 2012 Jul; 108(1):74-85. PubMed ID: 22535242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
    Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
    Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure.
    Koschinsky ML; Boffa MB; Nesheim ME; Zinman B; Hanley AJ; Harris SB; Cao H; Hegele RA
    Clin Genet; 2001 Nov; 60(5):345-9. PubMed ID: 11903334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site.
    Garand M; Lin JH; Hill CE; Zagorac B; Koschinsky ML; Boffa MB
    Cytokine; 2012 Mar; 57(3):389-97. PubMed ID: 22217421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
    Masuda Y; Yazawa J; Makino Y; Takada K
    Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone.
    Garand M; Lin JH; Zagorac B; Koschinsky ML; Boffa MB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):393-404. PubMed ID: 23429253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
    Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
    Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor.
    Maret D; Boffa MB; Brien DF; Nesheim ME; Koschinsky ML
    J Thromb Haemost; 2004 Nov; 2(11):1969-79. PubMed ID: 15550029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian-Indian population but may not be a risk for stroke.
    Biswas A; Tiwari AK; Ranjan R; Meena A; Akhter MS; Yadav BK; Behari M; Saxena R
    Br J Haematol; 2008 Nov; 143(4):581-8. PubMed ID: 18986391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.
    Henry M; Aubert H; Morange PE; Nanni I; Alessi MC; Tiret L; Juhan-Vague I
    Blood; 2001 Apr; 97(7):2053-8. PubMed ID: 11264171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.
    Boffa MB; Hamill JD; Maret D; Brown D; Scott ML; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Mar; 278(11):9250-7. PubMed ID: 12645517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thrombin-activatable fibrinolysis inhibitor (TAFI) is up-regulated by increase in intracellular cyclic AMP levels in cultured HepG2 cells.
    Ishii H; Kojima Y; Masuda Y; Takada K; Sugimoto K; Ikeda T
    Thromb Haemost; 2009 Dec; 102(6):1204-11. PubMed ID: 19967152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
    Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
    Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the CPB2 gene are maintained by balancing selection and result in haplotype-preferential splicing of exon 7.
    Cagliani R; Fumagalli M; Riva S; Pozzoli U; Fracassetti M; Bresolin N; Comi GP; Sironi M
    Mol Biol Evol; 2010 Aug; 27(8):1945-54. PubMed ID: 20237223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population.
    Li Y; Zeng Z; Zhao J; Ma G; Cui L; Tao H; Lin Z; Chen Y; Zhao B; Chen Y; Li K
    Lipids Health Dis; 2014 May; 13():80. PubMed ID: 24886076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders.
    Boffa MB; Nesheim ME; Koschinsky ML
    Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):59-74. PubMed ID: 12769657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.